582 filings
6-K
CSCI
COSCIENS Biopharma Inc.
23 Sep 24
COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs
7:30am
6-K
CSCI
COSCIENS Biopharma Inc.
27 Aug 24
COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
7:30am
6-K
CSCI
COSCIENS Biopharma Inc.
13 Aug 24
Current report (foreign)
8:05am
6-K
CSCI
COSCIENS Biopharma Inc.
13 Aug 24
COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
8:05am
6-K
CSCI
COSCIENS Biopharma Inc.
6 Aug 24
Current report (foreign)
6:22pm
6-K
37e5xsoxdwy3uqjt
16 Jul 24
Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders
6:25pm
6-K
7rq6vfno741fhn
25 Jun 24
Current report (foreign)
3:36pm
6-K
3x1ywi7
13 Jun 24
Company expects to report top-line data and complete study results in Q3 2024
9:20am
6-K
2hdqmjlefdm0esmaiw6a
10 Jun 24
Aeterna Zentaris and Ceapro Complete Merger Transaction
1:31pm
6-K/A
2yj5mrc7i240aolg68ks
29 May 24
Current report (foreign) (amended)
9:31pm
6-K
ech9zfa9bpjcf08z
17 May 24
Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
8:00am
6-K
7acjd azenf
15 May 24
Current report (foreign)
7:02pm
6-K
h43loc5gz8t3gi
14 May 24
Consolidated Financial Statements
6:44pm
6-K
nxoocyem txb3r
13 May 24
Current report (foreign)
6:48pm
6-K
nh3695fa r7
8 May 24
Material Change Report
8:21pm
6-K
o3m43laa
1 May 24
Aeterna Zentaris Announces Effective Date of Share Consolidation
4:51pm
6-K
l1w2ctpl 3b9g
28 Mar 24
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
10:28am
6-K
bp5munw
27 Mar 24
Consolidated Financial Statements
8:00am
6-K
mgofw5jjw1vf6610lcwc
27 Mar 24
Current report (foreign)
8:00am
6-K
xfxbyido
12 Mar 24
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
5:46pm